These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34936650)

  • 1. Assessing vaccination priorities for different ages and age-specific vaccination strategies of COVID-19 using an SEIR modelling approach.
    Yang C; Yang Y; Li Y
    PLoS One; 2021; 16(12):e0261236. PubMed ID: 34936650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity.
    Han S; Cai J; Yang J; Zhang J; Wu Q; Zheng W; Shi H; Ajelli M; Zhou XH; Yu H
    Nat Commun; 2021 Aug; 12(1):4673. PubMed ID: 34344871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
    Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
    J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of vaccination by priority group on UK deaths, hospital admissions and intensive care admissions from COVID-19.
    Cook TM; Roberts JV
    Anaesthesia; 2021 May; 76(5):608-616. PubMed ID: 33572007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 epidemic in New York City: development of an age group-specific mathematical model to predict the outcome of various vaccination strategies.
    Li M; Zu J; Zhang Y; Ma L; Shen M; Li Z; Ji F
    Virol J; 2022 Mar; 19(1):43. PubMed ID: 35292054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization.
    Miura F; Leung KY; Klinkenberg D; Ainslie KEC; Wallinga J
    PLoS Comput Biol; 2021 Dec; 17(12):e1009697. PubMed ID: 34898617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual preferences for COVID-19 vaccination in China.
    Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
    Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized delay of the second COVID-19 vaccine dose reduces ICU admissions.
    Silva PJS; Sagastizábal C; Nonato LG; Struchiner CJ; Pereira T
    Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34408076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranking the relative importance of COVID-19 vaccination strategies in Canada: a priority-setting exercise.
    Zhao L; Ismail SJ; Tunis MC
    CMAJ Open; 2021; 9(3):E848-E854. PubMed ID: 34493551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study.
    Foy BH; Wahl B; Mehta K; Shet A; Menon GI; Britto C
    Int J Infect Dis; 2021 Feb; 103():431-438. PubMed ID: 33388436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.
    Voigt A; Omholt S; Almaas E
    PLoS One; 2022; 17(2):e0263155. PubMed ID: 35108311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective vaccine allocation strategies, balancing economy with infection control against COVID-19 in Japan.
    Sunohara S; Asakura T; Kimura T; Ozawa S; Oshima S; Yamauchi D; Tamakoshi A
    PLoS One; 2021; 16(9):e0257107. PubMed ID: 34473809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing the COVID-19 vaccination behavior based on epidemic model with awareness-information.
    Zuo C; Zhu F; Meng Z; Ling Y; Zheng Y; Zhao X
    Infect Genet Evol; 2022 Mar; 98():105218. PubMed ID: 35066164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy.
    Paltiel AD; Schwartz JL; Zheng A; Walensky RP
    Health Aff (Millwood); 2021 Jan; 40(1):42-52. PubMed ID: 33211536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing Age-Specific Vaccination Strategies and Post-vaccination Reopening Policies for COVID-19 Control Using SEIR Modeling Approach.
    Wang X; Wu H; Tang S
    Bull Math Biol; 2022 Aug; 84(10):108. PubMed ID: 36029391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A deterministic transmission model for analytics-driven optimization of COVID-19 post-pandemic vaccination and quarantine strategies.
    Mahadhika CK; Aldila D
    Math Biosci Eng; 2024 Mar; 21(4):4956-4988. PubMed ID: 38872522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon.
    McDermott A
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34011611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.